Bilateral Ampiginous Choroiditis following Confirmed SARS-CoV-2 Infection.

Autor: Carvalho EM; Laboratory of Infectious Diseases in Ophthalmology, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Teixeira FHF; Laboratory of Infectious Diseases in Ophthalmology, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., de Carvalho Mendes Paiva A; Laboratory of Infectious Diseases in Ophthalmology, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Santos NS; Laboratory of Infectious Diseases in Ophthalmology, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Biancardi AL; Laboratory of Infectious Diseases in Ophthalmology, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Curi ALL; Laboratory of Infectious Diseases in Ophthalmology, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Jazyk: angličtina
Zdroj: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2023 May; Vol. 31 (4), pp. 843-846. Date of Electronic Publication: 2022 Apr 11.
DOI: 10.1080/09273948.2022.2049317
Abstrakt: Introduction: Ampiginous Choroiditis is a rare posterior uveitis that combines clinical features of Acute Multifocal Posterior Placoid Pigment Epitheliopathy and Serpiginous Chorioretinitis. Its pathophysiology is poorly understood and further studies are necessary to understand which mechanisms start the immunologic reaction.
Case Report: The purpose of this article is to report a well-documented case of Ampiginous Choroiditis following in seven days a RT-PCR confirmed SARS-CoV-2 infection, suggesting that the infection might have contributed as a trigger.
Conclusion: Timely diagnosis and correct treatment are paramount to improve the visual outcomes, and the patient had successful response to systemic steroids.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje